Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Basal-Like Breast Carcinoma”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Large-scale testing (Phase 3)Study completedNCT00130533
What this trial is testing

Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 876
Testing effectiveness (Phase 2)Study completedNCT01596751
What this trial is testing

Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Hope Rugo, MD 67
Early research (Phase 1)Study completedNCT00892736
What this trial is testing

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Who this might be right for
Basal-Like Breast CarcinomaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+14 more
National Cancer Institute (NCI) 98
Large-scale testing (Phase 3)Looking for participantsNCT05909332
What this trial is testing

Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Fudan University 764
Large-scale testing (Phase 3)Active Not RecruitingNCT02445391
What this trial is testing

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeInvasive Breast Carcinoma+9 more
ECOG-ACRIN Cancer Research Group 415
Early research (Phase 1)Ended earlyNCT01930292
What this trial is testing

Debio 1143 in Combination With Carboplatin and Paclitaxel in Patient With Advanced Solid Malignancies

Who this might be right for
Solid Tumors
Debiopharm International SA 31
Testing effectiveness (Phase 2)UnknownNCT00353717
What this trial is testing

Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma

Who this might be right for
Breast Neoplasms
Hadassah Medical Organization 25
Large-scale testing (Phase 3)WithdrawnNCT06585969
What this trial is testing

A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerER-positive Breast CancerLuminal B+2 more
Danish Breast Cancer Cooperative Group
Testing effectiveness (Phase 2)Ended earlyNCT00589238
What this trial is testing

Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 16
Testing effectiveness (Phase 2)Study completedNCT00463788
What this trial is testing

Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer

Who this might be right for
Breast Neoplasm
Merck KGaA, Darmstadt, Germany 181
Early research (Phase 1)Study completedNCT01650506
What this trial is testing

Study of Erlotinib and Metformin in Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Columbia University 8
Large-scale testing (Phase 3)Study completedNCT01881230
What this trial is testing

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

Who this might be right for
Breast TumorBreast CancerCancer of the Breast+8 more
Celgene 191
Large-scale testing (Phase 3)Not Yet RecruitingNCT07669610
What this trial is testing

An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Bevacizumab in First to Third Line BLIS Subtype TNBC

Who this might be right for
Breast CancerTriple Negative Breast Cancer (TNBC)
Fudan University 140